January 28, 2021 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 M&A, Partnerships Mass Spectrometry

Changi General Hospital and Shimadzu (Asia Pacific) jointly launch centre to conduct mass spectrometry-based clinical testing and research for personalised treatment

Changi General Hospital and Shimadzu (Asia Pacific) jointly launch centre to conduct mass spectrometry-based clinical testing and research for personalised treatment The Shimadzu-CGH Clinomics Centre (SC3) will improve turn-around time and clinical diagnostic accuracy of diseases such as hypertension and other endocrine conditions in adults SINGAPORE, 27 January 2021 – The Shimadzu-CGH Clinomics Centre (SC3),... Read more

January 27, 2021 Microscopy Product Launch

Stunning Images and Smart Features Make Olympus DP28 and DP23 Microscope Cameras Powerful Enough for Almost Any Life Science Imaging Application 

27 January, 2021Two new DP series cameras share advanced, time-saving features while enabling users to choose the most suitable model based on the level of resolution. With 4K ultra-high-definition image quality, the DP28 camera enables users to share and discuss sample images in fine detail while the DP23 camera’s 6.4-megapixel resolution and 45 frames per... Read more

January 27, 2021 Chromatography Product Launch

Waters Otto SPEcialist Positive Pressure Manifold Improves Reproducibility and Reliability of Solid-Phase Extraction (SPE)

Jan. 27, 2021 13:00 UTC Automation of a repetitive, but important, step in the process of preparing samples for LC and LC-MS/MS analysis enhances laboratory efficiency NEWS SUMMARY: New Waters Otto SPEcialist Positive Pressure Manifold minimizes user-to-user variability and improves reproducibility of analyte recoveries Semi-automated system improves SPE workflows and enables successful method transfer by... Read more

January 27, 2021 Cell Analysis Tools Product Launch

eNUVIO is Launching the OMEGA-96 Device

Fully high-throughput-compatible neuronal compartmentalization and co-culture microfluidic platform Caption: eNUVIO’s fully high-throughput-compatible microfluidic platform for neuronal compartmentalization. To download image, please click here. Montreal, Canada – January 27th 2021 – Life Science Newswire – On September 25th 2020 eNUVIO was pleased to introduce the latest microfabricated tool for neuronal compartmentalization and co-culture experiments: the OMEGA-96. Today, eNUVIO officially announced the launch of this unique product,... Read more

January 27, 2021 Life Science Tools Product Launch

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

Enables researchers to generate more data in less time to support both preclinical and clinical studies Uppsala, Sweden, 27 January 2021: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Bioaffy™ 4000 CD for immunoassay applications in biotherapeutic workflows. The new... Read more

January 27, 2021 Life Science Tools Product Launch

Swift Biosciences Releases Targeted S Gene Panel to Accelerate Surveillance of Emerging Strains of SARS-CoV-2

ANN ARBOR, Mich., Jan. 27, 2021 /PRNewswire/ — Swift Biosciences of Ann Arbor, MI  has released a targeted gene panel that covers 100% of the SARS-CoV-2 S gene, even with limited viral titers. The Swift Normalase® Amplicon SARS-CoV-2 S Gene Panel (SNAP) eliminates the need to perform qPCR for library normalization. A pioneer in the development of DNA and RNA library... Read more

January 27, 2021 Life Science Tools Liq. Handling & Robotics Product Launch

Clear Labs Launches Groundbreaking Solution for Enhanced Screening and Genomic Surveillance of SARS-CoV-2 and its Mutations

Leader in Next-Generation Sequencing Automation Workflow Solutions Delivers First Turn-key Solution for Whole Genome Sequencing (WGS) of COVID-19 SAN CARLOS, CALIF. (PRWEB) JANUARY 27, 2021 As the COVID-19 virus mutates, so does this growing list of variants, including B.1.1.7., B.1.351 and L452R. These variants, as well as future mutations, can now be identified in real-time by... Read more

January 27, 2021 PR/Corporate

Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call

MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more

January 27, 2021 PR/Corporate

Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call

MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more